- Report
- November 2021
- 365 Pages
Global
From €3340EUR$3,500USD£2,799GBP
- Book
- May 2022
- 240 Pages
- Book
- March 2022
- 896 Pages
- Book
- January 2022
- 720 Pages
- Book
- January 2020
- 424 Pages
- Book
- November 2024
- 336 Pages
- Book
- August 2013
- 580 Pages
- Book
- May 2021
- 1488 Pages
Global
- Book
- May 2021
- 1488 Pages
Global
- Book
- April 2014
- 1384 Pages

Bacteriophages, also known as phages, are viruses that infect and replicate within bacteria. They are of great interest to the biotechnology industry due to their potential to be used as therapeutic agents against bacterial infections. Phage therapy has been used for decades in Eastern Europe and is now gaining traction in the West as an alternative to antibiotics.
Phage therapy is being explored for a variety of applications, including the treatment of antibiotic-resistant infections, the prevention of biofilm formation, and the delivery of therapeutic proteins. Companies are developing phage-based products for a range of indications, including wound healing, skin care, and food safety.
The bacteriophage market is expected to grow significantly in the coming years as more companies enter the space and develop new products. Companies in the market include AmpliPhi Biosciences, Intralytix, Adaptive Phage Therapeutics, and Phagelux. Show Less Read more